Search
Menu
Home
HTB
2019
April
April 2019
Contents
Editorial
HTB 30 April 2019: vol 20 no 5 – BHIVA and CROI reports
Conference reports
25th Annual BHIVA Conference (BHIVA 2019)
BHIVA preconference: U=U and HIV and immigration detention
Conference on Retroviruses and Opportunistic Infections (CROI 2019): third reports
bNAb research at CROI 2019: vaccine, prevention, treatment and cure…
Paediatric dolutegravir update
Other cure related studies at CROI 2019
Antiretrovirals
Dual long-acting cabotegravir/rilpivirine injection submitted to FDA
Dolutegravir/3TC dual FDC (Dovato) approved in the US and given positive opinion in the EU
Other news
King’s launches transgender sexual health service with cliniQ
PDFs
30 April 2019 vol 20 no 5
HTB RSS
Early access
Long-acting CAB/RPV in people with suboptimal adherence: IMPALA study results at 48 weeks
17 July 2025
Potential for once-monthly oral PrEP using MK-8527
17 July 2025
Five doses a week could be a safe option for adults: crisis response to ART stock-outs
16 July 2025
5-on 2-off dosing is inferior to continuous ART in BREATHER Plus – but no difference in clinical outcomes
16 July 2025
All early access reports
Current issues
July 2025
June 2025
May 2025
Back issues
Special report
AIDS quilts at the Tate: reflection and also anger
8 July 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate